FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

GSK Plc’s Nucala approved in China as a treatment for CRSwNP

GSK's Nucala has been approved in China as an add-on treatment for CRSwNP, marking the first anti-IL-5 therapy for adults with this chronic condition...

Rio Tinto Plc 2025 dividend schedule and key event dates

Discover Rio Tinto plc's (LON:RIO) key financial and corporate event dates for 2025, including dividend announcements and annual general meetings...

Tim Cobbold named Chair of Spirax Group, succeeding Jamie Pike

Tim Cobbold becomes Chair of Spirax Group, succeeding Jamie Pike. Cobbold will lead Board initiatives and engage with shareholders to drive growth...

Vodafone Group Plc completes sale of its Italian operations to Swisscom

Vodafone Group Plc completes the sale of Vodafone Italy to Swisscom AG for €8 billion, aiding debt reduction and shareholder returns...

Aviva acquires Direct Line in £3.7 billion cash and share deal

Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders...

AstraZeneca’s Tagrisso approved in the EU for patients with unresectable NSCLC

AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials...

GSK Plc FIRST trial meetss primary endpoint in ovarian cancer

GSK reports success in phase III trial of Zejula and Jemperli for advanced ovarian cancer, achieving significant progression-free survival improvement...

Whitbread Plc Non-Executive Director Chris Kennedy to step down

Whitbread Plc announces Chris Kennedy's departure from the Board and Audit Committee Chair role after the 2025 AGM, with successor details to follow...

Rio Tinto appoints Georgie Bezette as Chief People Officer

Rio Tinto appoints Georgie Bezette as Chief People Officer, succeeding James Martin, to lead cultural transformation and talent development from 2025...

Kingfisher Plc sells Brico Dépôt Romania to Altex Romania

Kingfisher plc sells its Brico Dépôt Romania business to Altex Romania for €70m, aiming for strategic growth while ensuring operational excellence...

Landsec acquires 92% stake in Liverpool ONE shopping centre

Landsec acquires a 92% stake in Liverpool ONE for £490m, aligning with its strategy to expand and enhance top UK retail destinations...

Bunzl’s 2024 financial update: Growth, acquisitions and strategic plans

Bunzl plc forecasts a strong 2024 with revenue growth driven by acquisitions, despite deflation challenges, and announces a £200m buyback for 2025...

Kevin O’Byrne succeeds Scott Wheway as Centrica Plc Chair

Centrica plc announces Kevin O'Byrne as new Chair and Jo Harlow as Senior Independent Director, with Scott Wheway stepping down today...

GSK Plc receives US FDA Breakthrough Therapy Designation

GSK's Jemperli receives FDA Breakthrough Therapy Designation for treating locally advanced dMMR/MSI-H rectal cancer, expediting crucial development...

Kingfisher Plc appoints Lucinda Riches as a Non-Executive Director

Kingfisher plc welcomes Lucinda Riches as a new Non-Executive Director, joining the Board and committees in 2025, succeeding Rakhi Goss-Custard...

Bunzl plc Non-Executive Director and Chair of the Audit Committee Lloyd Pitchford to step down

Bunzl plc announces that Lloyd Pitchford will step down as Audit Committee Chair in April 2025, with Julia Wilson set to succeed him...
Search

Funds

FTSE 100

GSK Plc’s Nucala approved in China as a treatment for CRSwNP

GSK's Nucala has been approved in China as an add-on treatment for CRSwNP, marking the first anti-IL-5 therapy for adults with this chronic condition...

Rio Tinto Plc 2025 dividend schedule and key event dates

Discover Rio Tinto plc's (LON:RIO) key financial and corporate event dates for 2025, including dividend announcements and annual general meetings...

Tim Cobbold named Chair of Spirax Group, succeeding Jamie Pike

Tim Cobbold becomes Chair of Spirax Group, succeeding Jamie Pike. Cobbold will lead Board initiatives and engage with shareholders to drive growth...

Vodafone Group Plc completes sale of its Italian operations to Swisscom

Vodafone Group Plc completes the sale of Vodafone Italy to Swisscom AG for €8 billion, aiding debt reduction and shareholder returns...

Aviva acquires Direct Line in £3.7 billion cash and share deal

Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders...

AstraZeneca’s Tagrisso approved in the EU for patients with unresectable NSCLC

AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials...

GSK Plc FIRST trial meetss primary endpoint in ovarian cancer

GSK reports success in phase III trial of Zejula and Jemperli for advanced ovarian cancer, achieving significant progression-free survival improvement...

Whitbread Plc Non-Executive Director Chris Kennedy to step down

Whitbread Plc announces Chris Kennedy's departure from the Board and Audit Committee Chair role after the 2025 AGM, with successor details to follow...

Rio Tinto appoints Georgie Bezette as Chief People Officer

Rio Tinto appoints Georgie Bezette as Chief People Officer, succeeding James Martin, to lead cultural transformation and talent development from 2025...

Kingfisher Plc sells Brico Dépôt Romania to Altex Romania

Kingfisher plc sells its Brico Dépôt Romania business to Altex Romania for €70m, aiming for strategic growth while ensuring operational excellence...

Landsec acquires 92% stake in Liverpool ONE shopping centre

Landsec acquires a 92% stake in Liverpool ONE for £490m, aligning with its strategy to expand and enhance top UK retail destinations...

Bunzl’s 2024 financial update: Growth, acquisitions and strategic plans

Bunzl plc forecasts a strong 2024 with revenue growth driven by acquisitions, despite deflation challenges, and announces a £200m buyback for 2025...

Kevin O’Byrne succeeds Scott Wheway as Centrica Plc Chair

Centrica plc announces Kevin O'Byrne as new Chair and Jo Harlow as Senior Independent Director, with Scott Wheway stepping down today...

GSK Plc receives US FDA Breakthrough Therapy Designation

GSK's Jemperli receives FDA Breakthrough Therapy Designation for treating locally advanced dMMR/MSI-H rectal cancer, expediting crucial development...

Kingfisher Plc appoints Lucinda Riches as a Non-Executive Director

Kingfisher plc welcomes Lucinda Riches as a new Non-Executive Director, joining the Board and committees in 2025, succeeding Rakhi Goss-Custard...

Bunzl plc Non-Executive Director and Chair of the Audit Committee Lloyd Pitchford to step down

Bunzl plc announces that Lloyd Pitchford will step down as Audit Committee Chair in April 2025, with Julia Wilson set to succeed him...
Search

Funds

FTSE 100

FTSE 100

Funds